Recombinant Human Protein-Based Therapeutics (Promosome)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Human Protein-Based Therapeutics (Promosome)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPromosome LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPromosome LLC
Active IndicationsN/A
Inactive Indicationsalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A